L'Oreal buys British skincare brand Medik8

Time of India

4 hours ago

HighlightsL'Oreal is set to acquire the British skincare brand Medik8, enhancing its portfolio in the rapidly expanding dermatological skincare market. Medik8 specializes in vitamin A-based anti-aging creams and serums, and L'Oreal aims to strengthen its presence in existing markets while expanding globally. L'Oreal's dermatological beauty division has been its fastest-growing sector, achieving revenues of 7 billion euros in the previous year, driven by increasing consumer interest in science-backed skincare products.
L'Oreal
is to acquire British skincare brand
Medik8
, its owner, Britain-based private equity firm Inflexion, said on Monday, boosting the French cosmetics giant's offering in the fast-growing dermatological
skincare market
.
The size of the deal was not disclosed. Medik8 focuses on vitamin A-based anti-ageing creams and serums.
"The partnership with L'Oreal will allow Medik8 to deepen its presence in existing markets and expand globally. As part of the transaction, Inflexion will retain a minority shareholding in Medik8," the private equity firm said in a statement.
L'Oreal's dermatological beauty division, which includes major brands like
CeraVe
,
La Roche-Posay
, and
SkinCeuticals
, has been its fastest growing in recent years, reaching revenues of 7 billion euros ($7.99 billion) last year, after growing almost 10% on the year before.
The business, which also has the highest profit margin among its four divisions, has boomed on growing consumer interest in science-backed products, though growth has slowed recently due to rising competition.
L'Oreal executives said this year they were pursuing acquisitions and looking to revive flagging growth. The company acquired Korean skincare brand, Dr.G, in December and also bought a minority stake in Oman-based perfume house Amourage last year.